XETRA · CNW.DE
co.don AG
€0.25€0.00 (0.0%)
co.don AG’s quoted price sits in the lower half of its reported 52-week range, 89.57% below the high.
Loading market information…
XETRA · MF6.DE · EUR
Stock price, earnings
Quote as of Aug 1, 2022, 03:36 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
MagForce AG’s quoted price sits in the lower half of its reported 52-week range, 97.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow MagForce AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1997 and based in Berlin, Germany, MagForce AG specializes in developing and delivering nanotechnology-driven cancer treatments. The company's operations are primarily concentrated in Germany and Poland. Their core offerings include NanoTherm, a therapeutic solution specifically designed for addressing brain tumors. Complementing this therapy, they also provide NanoPlan, an advanced software tool that assists medical professionals in meticulously crafting optimal treatment strategies for NanoTherm, along with the NanoActivator, a specialized magnetic field generator integral to the treatment process.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:11 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€0.25€0.00 (0.0%)
co.don AG’s quoted price sits in the lower half of its reported 52-week range, 89.57% below the high.
€0.02€0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 88.28% below the high.
€0.13-€0.05 (-27.64%)
Medigene AG’s quoted price sits in the lower half of its reported 52-week range, 96.79% below the high.
€0.00+€0.00 (+14.29%)
High Fusion Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
€0.87€0.00 (0.0%)
Epigenomics AG’s quoted price sits in the lower half of its reported 52-week range, 45.28% below the high.
$0.00$0.00 (0.0%)
Molecule Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
€0.05€0.00 (0.0%)
Paion AG’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
€0.02€0.00 (0.0%)
Aladdin Healthcare Technologies SE’s quoted price sits in the lower half of its reported 52-week range, 91.9% below the high.
